Brain Monitoring Global Market Analysis 2024

$4,500.00$7,000.00

The Global Brain Monitoring Market is projected to reach $10.09 billion by 2028, from a value of $6.19 billion in 2022, by registering a CAGR of 8.5% during the forecast period 2022-2028

Clear
SKU: ER1042 Category:
© Epson Research 2021
Share this infographic on
Published Year:
2024
Region:
Global
Forecast period:
2021-2027
Report Coverage:

Market Trends and analysis of the crucial market segments across North America, Europe, Asia Pacific and Rest of the World.

Report Format:
PDF

5 User License

$ 5,500

  • Access to Five users
  • Print upto 5 copies
  • PDF & Excel Formats

Corporate User License

$ 7,000

  • Unlimited users within company
  • Free Yearly update
  • PDF & Excel Formats

The Global Brain Monitoring Market is projected to reach $10.09 billion by 2028, from a value of $6.19 billion in 2022, by registering a CAGR of 8.5% during the forecast period. An increase in the geriatric population, rising awareness of neurodegenerative disorders, and growing incidence of traumatic brain injuries are the major factors propelling the growth of the market. However, the high cost of complex brain monitoring procedures and devices is hampering the market growth. Moreover, technological advancements and the growing healthcare market in emerging economies are creating ample opportunities across the globe.

Recent Developments

In Nov 2021, Medtronic collaborated with Rune Labs to evaluate the use of Medtronic brainsense™ data in rune’s software for precision neurology. This collaboration will use Rune’s proprietary software platform to integrate, analyze, and display data captured from Medtronic’s Percept™ PC Neurostimulator, along with data from the StrivePD Apple Watch application and other sources.

In March 2018, Nihon Kohden launched its aireeg® WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments.

In March 2018, GE Healthcare launched SIGNA™ Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design new imaging tools, particularly to aid researchers in the detection of biomarkers for the potential diagnosis of mild Traumatic Brain Injury.

In March 2018, Philips Healthcare partnered with Samsung Electronics Co. Ltd. to connect Samsung’s ARTIK Smart IoT Platform to the Philips HealthSuite Digital Platform. This partnership will ultimately allow the Samsung ARTIK ecosystem of connected devices to safely access and share information with Philips’ cloud platform.

Competitive Landscape

Advanced Brain Monitoring, CAS Medical Systems, Medtronic, GE Healthcare, Neurosoft Technologies Ltd., Integra Lifesciences Holding Corporation, Philips Healthcare, Natus Medical Incorporated, Siemens Healthineers, Yokogawa Electric Corporation, Nonin Medical Inc., Masimo Corporation, Compumedics Ltd., Neural Analytics and Nihon Kohden are some of the major players in the global Brain Monitoring market.

TABLE OF CONTENTS

1 Summary
2 Market Overview
2.1 Abstract
2.2 Research Sources
2.3 Research Findings
2.4 Assumptions
3 Market Dynamics
3.1 Drivers & Opportunities
3.2 Restraints & Threats
3.3 Regulatory Affairs
3.4 Supplychain Analysis
3.5 PORTERS Analysis
4 Competitive Landscape
5 Brain Monitoring Market by Medical Condition
5.1 Alzheimer’s Disease
5.2 Dementia
5.3 Epilepsy
5.4 Headache Disorders
5.5 Sleep Disorders
5.6 Parkinson’s Disease
5.7 Huntington’s Disease
5.8 Stroke Disorder
5.9 Traumatic Brain Injury (TBI)
5.10 Other Medical Conditions
5.10.1 Attention-Deficit Hyperactivity Disorder
5.10.2 Autism
5.10.3 Depression
5.10.4 Dyslexia
5.10.5 Landau-Keffer Syndrome
5.10.6 Schizophrenia
5.10.7 Sickle-Cell Disease
5.10.8 Williams Syndrome
6 Brain Monitoring Market by Product
6.1 Modality
6.1.1 Portable Devices
6.1.2 Fixed Devices
6.2 Accessories
6.2.1 Batteries
6.2.2 Cables
6.2.3 Caps
6.2.4 Pastes & Gels
6.2.5 Sensors
6.2.6 Electrode
6.2.6.1 Dry Electrodes
6.2.6.2 Needle Electrodes
6.2.6.3 Wet Electrodes
6.3 Usability
6.3.1 Disposable
6.3.2 Reusable
6.4 Device
6.4.1 Cerebral Oximeters
6.4.2 Electroencephalograph (EEG) Devices
6.4.3 Functional Magnetic Resonance Imaging (fMRI) Scanners
6.4.4 Intracranial Pressure (ICP) Monitors
6.4.5 Magnetoencephalography (MEG) Devices
6.4.6 Positron Emission Tomography (PET) Scanners
6.4.7 Sleep Monitoring Devices
6.4.8 Transcranial Doppler (TCD) Devices
6.4.9 Computerized Tomography (CT) Scanners
6.4.10 Electromyography (EMG) Devices
6.5 Procedure
6.5.1 Devices for Non-Invasive Procedures
6.5.2 Devices for Invasive Procedures
7 Brain Monitoring Market by End User
7.1 Ambulances
7.2 Diagnostic Centers
7.3 Hospitals
7.4 Ambulatory Surgery Centers (ASCs) & Clinics
7.5 Neurological Centers and Institutions
7.6 Other End Users
7.6.1 Academic and Research Institutions
7.6.2 Home Care Settings
8 Brain Monitoring Market by Regions
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Rest of the World
9 Company Profiles
9.1 Advanced Brain Monitoring
9.2 CAS Medical Systems
9.3 Medtronic
9.4 GE Healthcare
9.5 Neurosoft Technologies Ltd.
9.6 Integra Lifesciences Holding Corporation
9.7 Philips Healthcare
9.8 Natus Medical Incorporated
9.9 Siemens Healthineers
9.10 Yokogawa Electric Corporation
9.11 Nonin Medical Inc.
9.12 Masimo Corporation
9.13 Compumedics Ltd.
9.14 Neural Analytics
9.15 Nihon Kohden